Luhan Yang is the founder of Qihan Biotech. Qihan Biotech has raised $75M in total funding. Latest round: Series B. Based in Hangzhou, China.
Luhan Yang is the CEO of Qihan Biotech, a Hangzhou-based gene-editing company developing pig organs for human transplantation and immune-privileged cell therapy platforms. He leads the company's mission to make cell and organ therapies universally available through multiplexable genome editing technology. Yang has overseen multiple financing rounds advancing the company's programs into preclinical and IND-enabling research.
Full founder directory · Investor directory · Company funding database · Fundraising library